In early November last year, industry group the American Council of Life Insurers (ACLI) published its annual Life Insurers Fact Book, the organisation’s deep dive in to a range of sub-categories of the US life insurance industry. As always, there are many notable takeaways from the document. Some of the most notable include the following:
Insurers are favouring funded re as it helps firms manage the market and longevity risks associated with writing bulk purchase annuity (BPA) business by reducing capital charges and therefore making PRT deals more competitive.
Unsurprisingly, given its growth and potential for capital optimisation, UK regulators have been carefully watching the increased use of funded re. In June 2023, the Prudential Regulatory Authority (PRA) sent a “Dear CRO’ letter to heads of risk at UK life insurers.
The letter outlined the regulator’s two main concerns from a sectoral review which it had carried out.
“One of the key risks arising in funded re is that firms recapture sub-optimal portfolios with depressed values and with limited ability to be transformed effectively to the firms’ preferred portfolio,” the PRA letter said.
Post a comment
Related Posts
Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions
Two recent litigation cases produced opposite results for the life settlement market.
Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet
Industry continues to model the potential upside of a successful rollout of MCED technology despite…
Emergence of Buy-In Deals Supports Third Biggest Year on Record for US Pension Risk Transfer Market
Highest ever volume of buy-in transactions show market in maturation stage.
Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales
Latest CMI model not likely to have material impact on pensions de-risking activity.
